Ratings
0
Nobody has rated this yet. Be the first!
Works
3
The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition
An immunogenic personal neoantigen vaccine for patients with melanoma
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
